These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 24451996)

  • 1. Effects of pH on nifekalant-induced electrophysiological change assessed in the Langendorff heart model of guinea pigs.
    Kazusa K; Nakamura Y; Watanabe Y; Ando K; Sugiyama A
    J Pharmacol Sci; 2014; 124(2):153-9. PubMed ID: 24451996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of cardiac α
    Kawakami S; Kambayashi R; Takada K; Aimoto M; Nagasawa Y; Takahara A
    J Pharmacol Sci; 2022 Oct; 150(2):67-73. PubMed ID: 36055753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effects of clinically available drugs on the repolarization process of the heart assessed by the in vivo canine models].
    Sugiyama A
    Nihon Yakurigaku Zasshi; 2003 Jun; 121(6):393-400. PubMed ID: 12835533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Electropharmacological and proarrhythmic effects of a class III antiarrhythmic drug nifekalant hydrochloride assessed using the in vivo canine models.
    Satoh Y; Sugiyama A; Takahara A; Chiba K; Hashimoto K
    J Cardiovasc Pharmacol; 2004 May; 43(5):715-23. PubMed ID: 15071360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Antiarrhythmic Action of the Na
    Kawakami S; Takada K; Aimoto M; Nagasawa Y; Kusakabe T; Kato K; Takahara A
    Biol Pharm Bull; 2023; 46(8):1120-1127. PubMed ID: 37532563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased short-term variability of repolarization predicts d-sotalol-induced torsades de pointes in dogs.
    Thomsen MB; Verduyn SC; Stengl M; Beekman JD; de Pater G; van Opstal J; Volders PG; Vos MA
    Circulation; 2004 Oct; 110(16):2453-9. PubMed ID: 15477402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proarrhythmia as a class effect of quinolones: increased dispersion of repolarization and triangulation of action potential predict torsades de pointes.
    Milberg P; Hilker E; Ramtin S; Cakir Y; Stypmann J; Engelen MA; Mönnig G; Osada N; Breithardt G; Haverkamp W; Eckardt L
    J Cardiovasc Electrophysiol; 2007 Jun; 18(6):647-54. PubMed ID: 17388913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Electrophysiologic profile of dronedarone on the ventricular level: beneficial effect on postrepolarization refractoriness in the presence of rapid phase 3 repolarization.
    Milberg P; Frommeyer G; Uphaus T; Kaiser D; Osada N; Breithardt G; Eckardt L
    J Cardiovasc Pharmacol; 2012 Jan; 59(1):92-100. PubMed ID: 21964157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of a typical I(Kr) channel blocker sematilide on the relationship between ventricular repolarization, refractoriness and onset of torsades de pointes.
    Sugiyama A; Hashimoto K
    Jpn J Pharmacol; 2002 Apr; 88(4):414-21. PubMed ID: 12046984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Azimilide and dofetilide produce similar electrophysiological and proarrhythmic effects in a canine model of Torsade de Pointes arrhythmias.
    Van Opstal JM; Leunissen JD; Wellens HJ; Vos MA
    Eur J Pharmacol; 2001 Jan; 412(1):67-76. PubMed ID: 11166738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new biomarker--index of cardiac electrophysiological balance (iCEB)--plays an important role in drug-induced cardiac arrhythmias: beyond QT-prolongation and Torsades de Pointes (TdPs).
    Lu HR; Yan GX; Gallacher DJ
    J Pharmacol Toxicol Methods; 2013; 68(2):250-259. PubMed ID: 23337247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monophasic action potentials in patients with torsades de pointes.
    Miwa S; Inoue T; Yokoyama M
    Jpn Circ J; 1994 Apr; 58(4):248-58. PubMed ID: 8051783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of nifekalant for acute conversion of atrial flutter: the possible termination mechanism of typical atrial flutter.
    Morita N; Tanaka K; Yodogawa K; Hayashi M; Akutsu K; Yamamoto T; Satoh N; Kobayashi Y; Katoh T; Takano T
    Pacing Clin Electrophysiol; 2007 Oct; 30(10):1242-53. PubMed ID: 17897127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Baseline values and sotalol-induced changes of ventricular repolarization duration, heterogeneity, and instability in patients with a history of drug-induced torsades de pointes.
    Couderc JP; Kaab S; Hinterseer M; McNitt S; Xia X; Fossa A; Beckmann BM; Polonsky S; Zareba W
    J Clin Pharmacol; 2009 Jan; 49(1):6-16. PubMed ID: 18957528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of transmural dispersion of repolarization in the genesis of drug-induced torsades de pointes.
    Antzelevitch C
    Heart Rhythm; 2005 Nov; 2(2 Suppl):S9-15. PubMed ID: 16253930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Models of torsades de pointes: effects of FPL64176, DPI201106, dofetilide, and chromanol 293B in isolated rabbit and guinea pig hearts.
    Cheng HC; Incardona J
    J Pharmacol Toxicol Methods; 2009; 60(2):174-84. PubMed ID: 19524054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the acute electrophysiologic effects of intravenous dronedarone, an amiodarone-like agent, with special emphasis on ventricular repolarization and acquired torsade de pointes arrhythmias.
    Verduyn SC; Vos MA; Leunissen HD; van Opstal JM; Wellens HJ
    J Cardiovasc Pharmacol; 1999 Feb; 33(2):212-22. PubMed ID: 10028928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hemodynamic and electrophysiological effects of mitemcinal (GM-611), a novel prokinetic agent derived from erythromycin in a halothane-anesthetized canine model.
    Kimura K; Tabo M; Mizoguchi K; Kato A; Suzuki M; Itoh Z; Omura S; Takanashi H
    J Toxicol Sci; 2007 Aug; 32(3):231-9. PubMed ID: 17785940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Anti-arrhythmic effects of taurine-magnesium coordination compound on torsades de pointes].
    Li Y; Sun K; An MY; Pan YY; Sun T; Yin YQ; Kang Y; Lou JS
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2018 Feb; 34(2):106-110. PubMed ID: 29926671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Physiological and pathological responses of TU waves to class Ia antiarrhythmic drugs.
    Maruyama T; Ohe T; Kurita T; Aihara N; Shimizu W
    Eur Heart J; 1995 May; 16(5):667-73. PubMed ID: 7588899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.